Our recent Life Sciences MoForum included in-depth discussions with industry insiders on the convergence of the life sciences with technology and healthcare and the trends that are driving the industry across the digital health, diagnostic, and drug markets.
Digital Transformation in the Life Sciences
The Digital Health sector had a record-breaking year across the board, with investment and M&A at an all-time high and funding for digital therapeutics and mental health tech more than doubled in the last year. Discussion topics included:
- Best practices for digital health partnerships
- How to attract the right partners whether you are a startup or a more established digital health company
- Defining your value proposition
- How to partner with payors and other research organizations
- Keeping up momentum
- Access and consumer adoption
- Focusing on personalization
- Reimbursement challenges
- Working with providers
View the recording here.
Future of Drug Discovery and Diagnostics
The life sciences industry has experienced tremendous change over the last decade and innovation is moving at a rapid rate, fueled not only by new technologies, but also by strategic collaborations to advance next-gen therapeutics and diagnostics in ways we have not seen before. Discussion topics included:
- How companies are sourcing deals to expand R&D and product pipelines
- The role of food to influence drug discovery and diagnostics and produce more positive outcomes for patients
- How companies are assessing new technologies to treat disease and the tools of the future that will lead to effective treatments and diagnostics
- Challenges for startups in drug discovery, including financing and finding the right talent in a competitive market
View the recording here.